LICENSE AGREEMENTS (Details) (USD $)	12 Months Ended				0 Months Ended
	Dec. 31, 2011	Dec. 31, 2013 License agreements GE Healthcare UK Limited	Dec. 31, 2012 License agreements GE Healthcare UK Limited	Dec. 31, 2011 License agreements GE Healthcare UK Limited	Jan. 05, 2011 License agreements Angiochem	Dec. 06, 2010 License agreements Angiochem	Dec. 05, 2012 License agreements TA Sciences
LICENSE AGREEMENTS
Revenues from collaborative agreements	$ 300,000	$ 0	$ 0	$ 300,000
License fee revenue		0	825,000	350,000
Paid upfront payment in cash						7,500,000
Issuance of common stock for acquired in-process research and development	27,500,000				27,500,000
Total upfront payment relating to acquired in-process research and development expensed						35,000,000
Shares of common stock issued against acquired in-process research and development					5,261,144
Number of days to be considered for closing price of common stock					5 days
Issuance of common stock for acquired in-process research and development	28,094,000				28,094,000
Acquired in-process research and development expense					594,000
Non-refundable upfront payment recognized in other income							$ 2,500,000